Respiratory Syncytial Virus Immunoprophylaxis: Issues in Short-term and Longer-term Impact
Pediatrics
.
2019 Jul;144(1):e20190153.
doi: 10.1542/peds.2019-0153.
Author
Leonard R Krilov
1
Affiliation
1
Children's Medical Center, NYU Winthrop Hospital, Mineola, New York and NYU Long Island School of Medicine, Mineola, New York leonard.krilov@nyulangone.org.
PMID:
31239288
DOI:
10.1542/peds.2019-0153
No abstract available
Publication types
Comment
MeSH terms
Antiviral Agents*
Cystic Fibrosis*
Humans
Palivizumab
Respiratory Syncytial Virus Infections*
Respiratory Syncytial Viruses
Substances
Antiviral Agents
Palivizumab